13 results
PRE 14A
VRNA
Verona Pharma Plc
8 Mar 24
Preliminary proxy
4:18pm
. The base salary payable to each named executive officer is intended to provide a fixed component of compensation reflecting the executive’s skill set
424B5
VRNA
Verona Pharma Plc
11 Aug 22
Prospectus supplement for primary offering
5:09pm
judgment;
to exercise reasonable care, skill and diligence;
not to accept benefits from a third party conferred by reason of his being a director
424B5
VRNA
Verona Pharma Plc
9 Aug 22
Prospectus supplement for primary offering
12:00am
;
to exercise reasonable care, skill and diligence;
not to accept benefits from a third party conferred by reason of his being a director or doing
S-3
EX-4.5
btsdk4b0x8nq4fqjj
19 Mar 21
Shelf registration
5:23pm
S-3
7gi647r i7qyjd
19 Mar 21
Shelf registration
5:23pm
POS AM
l55hy7prdcldw
19 Mar 21
Prospectus update (post-effective amendment)
4:56pm
DEF 14A
1ml 9ica667tu
19 Mar 21
Definitive proxy
4:02pm
10-K
EX-4.5
2lv6os
25 Feb 21
Annual report
8:29am
F-3
6as87ckf5kp4bj66x
22 May 18
Shelf registration (foreign)
4:19pm
- Prev
- 1
- Next